AEMD
Aethlon Medical Inc
Going-concern doubt
— flagged Jun 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management concluded that there were conditions and events which raised substantial doubt as to the Company’s ability to continue as a going concern within twelve months after the date of the issuance of the financial statements included in this Annual Report.”View the 10-K filed Jun 10, 2026
Company with tickers: AEMD
CIK
882291
CUSIP
00808Y604
Shares Outstanding
2,370,560
Website
https://www.aethlonmedical.com
Investor Relations
https://www.aethlonmedical.com/investors
13F Activity (30d)
1 filings
1 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $7,293,631 | USD | 2026-03-31 | 10-K | 2026-06-10 |
| Research & Development | $1,912,000 | USD | 2026-03-31 | 10-K | 2026-06-10 |
| Operating Income | $-7,293,631 | USD | 2026-03-31 | 10-K | 2026-06-10 |
| Net Income | $-7,151,469 | USD | 2026-03-31 | 10-K | 2026-06-10 |
| EPS (Basic) | $-0.41 | USD/shares | 2026-03-31 | 10-K | 2026-06-10 |
| EPS (Diluted) | $-0.41 | USD/shares | 2026-03-31 | 10-K | 2026-06-10 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Segment (USD)
| Component | 2021-03-31 | 2022-03-31 |
|---|---|---|
| Aethlon | $659,104 | $294,165 |
By Product & Service (USD)
| Component | 2021-03-31 | 2022-03-31 |
|---|---|---|
| Govt Contract And Grant Revenue | $659,104 | $294,165 |